🔬
Foundation Sciences · Embryology
Neural Tube Development
The neural tube forms by neurulation in week 3–4 and gives rise to the entire central nervous system; failure of closure produces neural tube defects (NTDs).
📌 Learning Objectives
- Describe the underlying mechanism of Neural Tube Development.
- Identify the key clinical features and complications of Neural Tube Development.
- Outline the appropriate investigations and management of Neural Tube Development.
- Discuss the implications for patients and families of Neural Tube Development.
📋 Overview
The neural plate folds and fuses, beginning in the cervical region and proceeding cranially and caudally. Closure of the cranial neuropore (~day 25) and caudal neuropore (~day 28) completes the tube.
🔬 Basic Science
The neural plate folds and fuses, beginning in the cervical region and proceeding cranially and caudally. Closure of the cranial neuropore (~day 25) and caudal neuropore (~day 28) completes the tube.
🏥 Clinical Relevance
Periconceptual folic acid (400 µg/day, 5 mg if high risk) reduces NTD risk by ~70%.
🧪 Investigations
Investigation depends on clinical context: relevant blood tests, imaging, and specific genetic or histopathological tests as appropriate. Refer to specialist services where indicated.
💊 Management
Management is condition-specific and typically multidisciplinary, combining medical therapy, surgical intervention where appropriate, supportive care, and family/genetic counselling.
Revision Resources – expand the sections below for high-yield notes, exam pearls, key facts and further reading.
MLA High-Yield Notes & Quick Revision ⌄
Common SBA themes: recognising the underlying mechanism, identifying classic clinical features, and choosing the first-line investigation or management step. Watch for inheritance pattern and characteristic associations.
neural tube
neurulation
spina bifida
anencephaly
folic acid
- Cranial neuropore closes ~day 25; caudal neuropore closes ~day 28.
- Anencephaly results from failed cranial neuropore closure.
- Spina bifida occulta is the mildest form; meningomyelocele is most severe.
- Folic acid supplementation reduces NTD risk by ~70%.
- Raised maternal serum alpha-fetoprotein suggests open NTD.
Exam Pearls ⌄
⭐ High Yield
Cranial neuropore closes ~day 25; caudal neuropore closes ~day 28.
Anencephaly results from failed cranial neuropore closure.
Spina bifida occulta is the mildest form; meningomyelocele is most severe.
Folic acid supplementation reduces NTD risk by ~70%.
Raised maternal serum alpha-fetoprotein suggests open NTD.
💡 Clinical Pearl
Neural Tube: Periconceptual folic acid (400 µg/day, 5 mg if high risk) reduces NTD risk by ~70%.
⚠️ Exam Tip — Common Mistakes
Confusing the mechanism of Neural Tube Development with related conditions.
Missing classic clinical features of Neural Tube Development in SBA stems.
Failing to consider Neural Tube Development in the differential diagnosis.
Key Facts ⌄
Cranial neuropore closes ~day 25; caudal neuropore closes ~day 28.
Anencephaly results from failed cranial neuropore closure.
Spina bifida occulta is the mildest form; meningomyelocele is most severe.
Folic acid supplementation reduces NTD risk by ~70%.
Raised maternal serum alpha-fetoprotein suggests open NTD.
Related Topics ⌄
References ⌄
- GMC MLA Content Map
- NICE Clinical Knowledge Summaries
- BMJ Best Practice
Further Resources
Medical Portfolio & Career Development
Build a professional portfolio website for applications, audits, teaching, research and career progression.
CVtoWebsite.com →